To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
Fifth Annual KHI Stakeholders Meeting
The Fifth Annual KHI Stakeholders Meeting will take place in the Washington, DC area on May 24-25, 2017. The Stakeholders Meeting will bring together our diverse membership from the kidney community to connect members across different fields, share ideas, collect feedback, and collaborate on new and proposed projects.
Housing and Registration is now open. Click here for more information.
Innovative Alternatives to Renal Replacement Therapy: Developing a Roadmap Workshop
KHI hosted a public workshop, with involvement from the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS), to discuss the scientific, technical, and regulatory roadmap to create a bioartificial or bioengineered alternative to dialysis.
The workshop titled Innovative Alternatives to Renal Replacement Therapy: Developing a Roadmap was held on March 23-24 in Silver Spring, MD.
For more information, please click here.
This workshop highlights KHI's efforts to enhance patient safety and foster innovation in kidney disease and is part of the broader commitment KHI made during the White House Organ Summit in June 2016.
If you have any questions or would like to learn more about this workshop, please email email@example.com.
KHI Annual Report 2016
On behalf of the Board of Directors, we would like to thank the KHI membership for their participation in KHI, which has seen its membership grow from 47 organizations in September 2013, to more than 75 organizations in December 2016. The membership has worked diligently through KHI to improve patient safety and promote the development of optimal therapies for diseases that affect kidneys and the quality of life for millions of people.
View KHI's 2016 Annual Report.
View KHI's 2015 Annual Report.
View the KHI Inaugural Review 2012-2014.
Open Call for Workgroups
The following is a list of current opportunities for KHI members to volunteer their service on a project workgroup. Click on the title for more information and details on how to volunteer.
Involvement in workgroups is on a voluntary basis with no compensation provided. All workgroup members are required to submit an online disclosure form with their application.
If you have any questions about KHI, or would like more information about becoming a member, please contact firstname.lastname@example.org.